Stay updated on XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check41 days agoChange DetectedThe website has updated its status to 'Active, not recruiting' as of January 30, 2025, while the previous 'Recruiting' status has been removed.SummaryDifference2%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check70 days agoChange DetectedA new addition has been made on December 31, 2024, while a previous entry was deleted on December 2, 2024.SummaryDifference0.3%
Stay in the know with updates to XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.